FDA to Review Biofrontera’s sNDA for Ameluz Dosage Increase
The U.S. Food and Drug Administration (FDA) has issued a “no filing review issues identified” letter regarding Biofrontera’s sNDA (supplementary New Drug Application) which aims to increase the maximally approved dosage from one to three tubes of Ameluz per treatment. The FDA has completed its filing review and will begin its substantive review of Biofrontera’s communication with […]
Diagnosing Skin Disease in Images of Darker Skin: Can AI Help?
When diagnosing skin diseases based solely on images, doctors don’t perform as well when the patient has darker skin, according to a new study from MIT researchers. The study, which included more than 1,000 dermatologists and general practitioners, found that dermatologists accurately characterized about 38% of the images they saw, but only 34% of those that showed […]
Don’t Miss Out: ASA Announces 2024 Grant Opportunities for Dermatology Researchers
The American Skin Association (ASA) announced its 2024 grant opportunities for dermatologists treating skin cancer and other diseases. “ASA is proud to announce that the 2024 grant opportunities to support medical and educational initiatives total nearly $750,000, which is the largest offering to date,” says ASA Chairman Howard P. Milstein in a news release. “For […]